Stability constants of Cu(II)-piroxicam complexes in solution: a DFT study

  • Lydia G. Ledesma-Olvera
  • Esther Agacino-Valdés
  • Rodolfo Gómez-Balderas
Regular Article
First Online:
Received:
Accepted:
  • 251 Downloads
Part of the following topical collections:
  1. Festschrift in honour of A. Vela

Abstract

Knowledge of coordination modes of metal and pharmaceuticals are crucial for gaining understanding of the chemical mechanisms underlying their biological activity, in particular for systems where there is a synergism based on the fact that complexes can provide enhanced activity of the drug with fewer side effects. Quantum chemistry calculations represent a unique and complementary approach to experimental methods to understand the thermodynamics of reactions in terms of structural details of the participating species. Here, the coordination modes between Cu(II) and piroxicam and their stability constants were studied, by means of DFT molecular modeling, in gas phase and in solution (water and ethanol) at the RevTPSS/def-SVP and (SMD- and CPCM-RevTPSS)/def-SVP levels of theory, respectively. Octahedral bidentate geometries are found to be the more stable, likely due to the chelate effect. Thermodynamic results on the stability of the formed complexes revealed that complexation is favored in ethanol. The calculated logK s with the (SMD-RevTPSS)/def-SVP level of theory are in better agreement to the experimental values than (CPCM-RevTPSS)/def-SVP results.

Keywords

Cu(II)-piroxicam Theoretical stability constants Solvent effects Anti-inflammatory 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

L. G. L. -O acknowledges Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México, for the scholarship to pursue her major in Chemistry. This research was conducted under grants PAPIIT Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México IN222914 and PIAPI Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México C23. Authors acknowledge Red Mexicana de Fisicoquímica Teórica (CONACyT) under grants 253498 and 271361, for supporting this investigation. We gratefully acknowledge the generous computing time provided by Dirección General de Cómputo y de Tecnologías de Información y Comunicación, Universidad Nacional Autónoma de México through the grants SC16-1-IR-100 and SC16-1-IR-112.

Supplementary material

214_2016_1996_MOESM1_ESM.docx (17 kb)
Supplementary material 1 (DOCX 17 kb)
214_2016_1996_MOESM2_ESM.rtf (88 kb)
Supplementary material 2 (RTF 88 kb)

References

  1. 1.
    Page J, Henry D (2000) Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Int Med 160:777–784CrossRefGoogle Scholar
  2. 2.
    McGeer PL, Schilzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 17 epidemiologic studies. Neurology 47:425–432CrossRefGoogle Scholar
  3. 3.
    Sugaya K, Uz T, Kumar V, Manev H (2000) New anti-inflammatory treatment strategy in Alzheimer’s disease. Jpn J Pharmacol 82:85–94CrossRefGoogle Scholar
  4. 4.
    Jain AK (2008) Solubilization of indomethacin using hydrotropes for aqueous injection. Eur J Pharm Biopharm 68:701–714CrossRefGoogle Scholar
  5. 5.
    Williams PAM, Molinuevo MS, Okulik N, Jubert AH, Etcheverry S (2005) Synthesis, characterization and biological properties of vanadyl (IV) complexes of diclofenac and indomethacin: an experimental and theoretical study. Appl Organomet Chem 19:711–718CrossRefGoogle Scholar
  6. 6.
    McNally R (2001) Drug information for health care professional, 21st edn. USP–DI, MassachusettsGoogle Scholar
  7. 7.
    Moncada S, Vane JR (1979) Mode of action of aspirin-like drugs. Adv Int Med 24:1–22Google Scholar
  8. 8.
    Mamett LJ, Kalgutkar AS (1999) Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. Trends Pharmacol Sci 20:465–469CrossRefGoogle Scholar
  9. 9.
    Weder JE, Dillon CT, Hambley TW, Kennedy BJ, Lay PA, Biffin JR, Regtop HL, Davies NM (2002) Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized. Coord Chem Rev 232:95–126CrossRefGoogle Scholar
  10. 10.
    Christofis P, Katsarou M, Papakyriakou A, Sanakis Y, Katsaros N, Psomas G (2005) Mononuclear metal complexes with piroxicam: synthesis, structure and biological activity. J Inorg Biochem 99:2197–2210CrossRefGoogle Scholar
  11. 11.
    Ho J, Coote ML, Franco-Pérez M, Gómez-Balderas R (2010) First-principles prediction of the pKas of anti-inflammatory oxicams. J Phys Chem A 114:11992–12003CrossRefGoogle Scholar
  12. 12.
    Milanino R, Mauro U, Marrella M, Pasqualicchio M, Gaspe − Rini R, Velo G (1995) In: Berthon G (ed) Handbook of metal-ligand interactions in biological fluids. Marcel Decker, New YorkGoogle Scholar
  13. 13.
    Sorenson JRJ (1989) Copper complexes offer a physiological approach to treatment of chronic diseases. Prog Med Chem 26:437–568CrossRefGoogle Scholar
  14. 14.
    Tagliati CA, Kimura E, Nothenberg MS, Santos SRJC, Oga S (1999) Pharmacokinetic profile and adverse gastric effect of zinc-piroxicam in rats. Gen Pharmacol 33:67–71CrossRefGoogle Scholar
  15. 15.
    Samara CD, Tsotsou G, Ekateriniadou LV, Kortsaris AH, Raptopoulou CP, Terzis A, Kyriakidis DA, Kersissoglou DP (1998) Anti-inflammatory drugs interacting with Zn(II), Cd(II) and Pt(II) metal ions. J Inorg Biochem 71:171–179CrossRefGoogle Scholar
  16. 16.
    Rodríguez-Laguna N, Reyes-García LI, Moya-Hernández R, Rojas-Hernández A, Gómez-Balderas (2016) Chemical speciation of the system Cu(II)-indomethacin in ethanol and water by UV–Vis spectrophotometry. J Chem. doi: 10.1155/2016/9804162
  17. 17.
    Cini R, Giorgi G, Cinquantini A, Rossi C, Sabat M (1990) Metal complexes of the anti-inflammatory drug piroxicam. Inorg Chem 29:5197–5200CrossRefGoogle Scholar
  18. 18.
    Gehad GM, El-Gamel NEA (2004) Preparation and spectroscopic characterization of metal complexes of piroxicam. Vib Spectrosc 36:97–104CrossRefGoogle Scholar
  19. 19.
    Gehad GM (2005) Structural and thermal characterization of ternary complexes of piroxicam and alanine with transition metals: uranyl binary and ternary complexes of piroxicam Spectroscopic characterization and properties of metal complexes. Spectrochim Acta A 62:1165–1171CrossRefGoogle Scholar
  20. 20.
    Roy S, Banerjee R, Sarkar M (2006) Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone. J Inorg Biochem 100:1320–1331CrossRefGoogle Scholar
  21. 21.
    Tamasi G, Serinelli F, Consumi M, Magnani A, Casolaro M, Cini R (2008) Release studies from smart hydrogels as carriers for piroxicam and copper(II)-oxicam complexes as anti-inflammatory and anti-cancer drugs. X-ray structures of new copper(II)-piroxicam and -isoxicam complex molecules. J Inorg Biochem 102:1862–1873CrossRefGoogle Scholar
  22. 22.
    Hadadzadeh H, Salimi M, Weil M, Jannesari Z, Darabi F, Abdi K, Khalaji AD, Sardari S, Ahangari R (2012) The piroxicam complex of copper(II), trans-[Cu(Pir)2(THF)2], and its interaction with DNA. J Mol Struct 1022:172–180CrossRefGoogle Scholar
  23. 23.
    Abu-Eittah RH, Zordok WA (2010) A molecular orbital treatment of piroxicam and its M2+-complexes: the change of the drug configuration in a time of bond formation. J Mol Struct Theochem 951:14–20CrossRefGoogle Scholar
  24. 24.
    Gaussian 09, Revision D.01, Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA Jr., Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Keith T, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas O, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ (2009) Gaussian Inc., Wallingford CTGoogle Scholar
  25. 25.
    GaussView, Version 5, Dennington R, Keith T, Millam J (2009) Semichem Inc., Shawnee Mission, KSGoogle Scholar
  26. 26.
    Zhao Y, Truhlar DG (2006) A new local density functional for main-group thermochemistry, transition metal bonding, thermochemical kinetics, and non-covalent interactions. J Chem Phys 125:194101-1–194101-18Google Scholar
  27. 27.
    Zhao Y, Truhlar DG (2008) The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, non-covalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functional and 12 other functionals. Theor Chem Acc 120:215–241CrossRefGoogle Scholar
  28. 28.
    Perdew JP, Ruzsinszky A, Csonka GI, Constantin LA, Sun J (2009) Workhorse semilocal density functional for condensed matter physics and quantum chemistry. Phys Rev Lett 103:026403-1–026403-4CrossRefGoogle Scholar
  29. 29.
    Becke AD (1993) Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 98:5648–5652CrossRefGoogle Scholar
  30. 30.
    Lee C, Yang W, Parr RG (1988) Development of the Colic–Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 37:785–789CrossRefGoogle Scholar
  31. 31.
    Eichkorn K, Weigend F, Treutler O, Ahlrichs R (1997) Auxiliary basis sets for main row atoms and transition metals and their use to approximate Coulomb potentials. Theor Chem Acc 97:119–124CrossRefGoogle Scholar
  32. 32.
    Gutten O, Besseová I, Rulísek L (2011) Interaction of metal ions with biomolecular ligands: how accurate are calculated free energies associated with metal ion complexation? J Phys Chem 115:11394–11402CrossRefGoogle Scholar
  33. 33.
    Barone V, Cossi M (1998) Quantum calculation of molecular energies and energy gradients in solution by a conductor solvent model. J Phys Chem A 102:1995–2001CrossRefGoogle Scholar
  34. 34.
    Cossi M, Rega N, Scalmani G, Barone V (2003) Energies, structures, and electronic properties of molecules in solution with the C-PCM solvation model. J Comp Chem 24:669–681CrossRefGoogle Scholar
  35. 35.
    Marenich AV, Cramer CJ, Truhlar DG (2009) Universal solvation model based on solute electron density and on a continuum model of the solvent defined by the bulk dielectric constant and atomic surface tensions. J Phys Chem B 113:6378–6396CrossRefGoogle Scholar
  36. 36.
    NIST Computational Chemistry Comparison and Benchmark Database (2016) NIST standard reference database number 101 release 16a, August 2013. In: Russell D Johnson III (ed) (http://cccbdb.nist.gov/). Accessed 28 Apr 2016
  37. 37.
    Okuno Y (1997) Theoretical investigation of the mechanism of the Baeyer–Villiger reaction in nonpolar solvents. Chem Eur J 3:212CrossRefGoogle Scholar
  38. 38.
    Benson SW (1982) The foundations of chemical kinetics. Krieger, FloridaGoogle Scholar
  39. 39.
    Ardura D, Lopez R, Sordo TL (2005) Relative Gibbs energies in solution through continuum models: effect of the loss of translational degrees of freedom in bimolecular reactions on Gibbs energy barriers. J Phys Chem B 109:23618–23623CrossRefGoogle Scholar
  40. 40.
    Alvarez-Idaboy JR, Reyes L, Cruz J (2006) A new specific mechanism for the acid catalysis of the addition step in the Baeyer–Villiger rearrangement. Org Lett 8:1763–1765CrossRefGoogle Scholar
  41. 41.
    Galano A (2007) Influence of silicon defects on the adsorption of thiophene-like compounds on polycyclic aromatic hydrocarbons: a theoretical study using thiophene + coronae as the simplest model. J Phys Chem A 111:1677–1682CrossRefGoogle Scholar
  42. 42.
    Matěj P, Jaroslav VB (2005) Theoretical description of copper Cu(I)/Cu(II) complexes in mixed ammine-aqua environment. DFT and ab initio quantum chemical study. Chem Phys 312:193–204CrossRefGoogle Scholar
  43. 43.
    Sotomayor RG, Holguín AR, Romdhani A, Martinez F, Jouyban A (2013) Solution thermodynamics of piroxicam in some ethanol + water mixtures and correlation with the Jouyban–Acree model. J Solut Chem 42:358–371CrossRefGoogle Scholar
  44. 44.
    Ivanova D, Deneva V, Nedeltcheva D, Kamounah FS, Gergov G, Hansen PE, Kawauchi S, Antonov L (2015) Tautomeric transformations of piroxicam in solution: a combined experimental and theoretical study. RSC Adv 5:31852–31860CrossRefGoogle Scholar
  45. 45.
    Ferreira de Souza K, Martins JA, Pessine FBT, Custodio R (2010) A theoretical and spectroscopic study of conformational structures of piroxicam. Spectrochim Acta Part A 75:901–907CrossRefGoogle Scholar
  46. 46.
    Allen LC (1975) A simple model of hydrogen bonding. J Am Chem Soc 97:6921–6940CrossRefGoogle Scholar
  47. 47.
    Tita B, Rusu G, Tita D (2013) Thermal behaviour of active substance versus pharmaceutical compounds for Ibuprofen. Rev Chim (Bucharest) 64:472–476Google Scholar
  48. 48.
    Cini R, Pogni R, Basosi R, Donati A, Rossi C, Sabadini L, Rollo L, Lorenzini S, Gelli R, Marcolongo R (1995) Oxigen radical scavenger activity, EPR, NMR, molecular mechanism and extended-Hückel molecular orbital investigation of the bis(piroxicam)Cu(II) complex. Met Based Drugs 2:43–56CrossRefGoogle Scholar
  49. 49.
    Méndez-Rojas MA, Cordova-Lozano F, Gojon-Zorrilla G, González-Vergara E, Quiroz MA (1999) Direct electrosynthesis of Cu, Cd, Zn complexes of piroxicam (4-hydroxy-2-methyl-N-(2-pyridyl) -2H-1,2-benzothiazine-3-carboxamide-1,1,-dioxide) and isoxicam (4-hydroxy-2-methyl-N-(5-methyl-3-isoxazolyl)-2H-1, 2-benzothiazine-3-carboxamide-1,1 dioxide) in non aqueous media by insitu generation of supporting electrolyte. Polyhedron 18:2651–2658CrossRefGoogle Scholar
  50. 50.
    Gehad GM, El-Gamel NEA (2004) Synthesis, investigation and spectroscopic characterization of piroxicam ternary complexes of Fe(II), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) with glycine and dl-phenylalanine. Spectrochim Acta Part A Mol Biomol Spect 60:3141–3154CrossRefGoogle Scholar
  51. 51.
    Pasquarello A, Petri I, Salmon PS, Parisel O, Car R, Tóth E, Powell DH, Fischer HE, Helm L, Merbach AE (2001) First solvation shell of the Cu(II) aqua ion: evidence for fivefold coordination. Science 291:856–859CrossRefGoogle Scholar
  52. 52.
    Bérces A, Nudaka T, Margl P, Ziegler T (1999) Solvation of Cu2+ in water and ammonia. Insight from static and dynamical density functional theory. J Phys Chem A 103:9693–9701CrossRefGoogle Scholar
  53. 53.
    Salmon PS, Howells WS, Mills R (1987) The dynamics of water molecules in ionic solution. II. Quasi-elastic neutron scattering and tracer diffusion studies of the proton and ion dynamics in concentrated Ni2+, Cu2+ and Nd3+ aqueous solutions. J Phys C Solid State Phys 20:5727CrossRefGoogle Scholar
  54. 54.
    El-Maali NA, Vire JC, Patriarche GJ, Ghandour MA (1989) Copper (II), lead (II) and cadmium (II) complexes with the antiinflammatory drugs piroxicam and tenoxicam. Anal Lett 22:3025–3039CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  1. 1.Centro de Investigaciones Teóricas, Facultad de Estudios Superiores CuautitlanUniversidad Nacional Autónoma de MéxicoCuautitlan IzcalliMéxico
  2. 2.Laboratorio de Fisicoquímica Analítica, Unidad de Investigación Multidisciplinaria, Facultad de Estudios Superiores CuautitlánUniversidad Nacional Autónoma de MéxicoCuautitlan IzcalliMéxico

Personalised recommendations